Although respiratory syncytial virus (RSV) is common and often mild, it's associated with morbidity and mortality among people aged 60 and older and in adults with underlying conditions. Fewer than half of US adults at highest risk for severe...
Although respiratory syncytial virus (RSV) is common and often mild, it's associated with morbidity and mortality among people aged 60 and older and in adults with underlying conditions. Fewer than half of US adults at highest risk for severe...
The following is a summary of “Growing Awareness: Limited Testing and Screening Bias for Hepatitis Delta Virus in Utah 2000–2021,” published in the March 2024 issue of Infectious Disease by Hesterman, et al. Researchers launched a historical analysis to investigate...
Although RSV is common and often mild, it is associated with morbidity and mortality among people aged 60 and older and in adults with underlying conditions.
Dolutegravir + lamivudine (DTG + 3TC) is a first-line regimen for people with HIV. However, there are still concerns about its efficacy in people with tuberculosis (TB)/HIV due to the lack of available evidence and drug-drug interaction with rifampicin.A...
The following is a summary of "Pathogenicity of vancomycin-resistant Enterococcus faecalis to colon cancer cells," published in the February 2024 issue of Infectious Disease by Zhang et al. Researchers conducted a retrospective study to examine how...
The following is a summary of “COVID-19-associated mortality in individuals with serious mental disorders in Sweden during the first two years of the pandemic– a population-based register study,” published in the March 2024 issue of Psychiatry by Gibbs, et al....
The following is a summary of “Growing Awareness: Limited Testing and Screening Bias for Hepatitis Delta Virus in Utah 2000–2021,” published in the March 2024 issue of Infectious Disease by Hesterman, et al. Researchers launched a historical analysis to investigate...
Although RSV is common and often mild, it is associated with morbidity and mortality among people aged 60 and older and in adults with underlying conditions.
Dolutegravir + lamivudine (DTG + 3TC) is a first-line regimen for people with HIV. However, there are still concerns about its efficacy in people with tuberculosis (TB)/HIV due to the lack of available evidence and drug-drug interaction with rifampicin.A...
The following is a summary of "Pathogenicity of vancomycin-resistant Enterococcus faecalis to colon cancer cells," published in the February 2024 issue of Infectious Disease by Zhang et al. Researchers conducted a retrospective study to examine how...
The following is a summary of “COVID-19-associated mortality in individuals with serious mental disorders in Sweden during the first two years of the pandemic– a population-based register study,” published in the March 2024 issue of Psychiatry by Gibbs, et al....
The latest news from CROI 2023 on HIV, includes abstracts, featured articles, and information about the conference.
Healthcare providers are particularly vulnerable to litigation. Here are some tips to help prepare for the possibility of a medical malpractice lawsuit.
Patrice Benjamin Piebald is an abrasive endocrinologist with bipolar disorder who meets an unexpected fate after a series of confrontations with colleagues.
Doris, a woman battling a dire diagnosis, takes matters into her own hands during a medical conference attended by the insurance company CEO.
Metabolic syndrome (MetS) score trajectories are associated with a subsequent risk for cancer, according to a study published online March 11 in Cancer. Li Deng, Ph.D., from Beijing Shijitan Hospital, and colleagues examined the relationship between MetS score...
Wait time targets and patient feedback significantly cut prescription service wait times by 17% and 37%, improving satisfaction in the hospital study.
When patients look online for answers to medical questions, healthcare providers must ensure their patients act upon science-backed medical information.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.